INT MEDICAL (01501) announced that on January 14, 2026 (after trading hours), the company entered into a placement agreement with joint placing agents. The company intends to issue 35.2 million placement shares through the joint placing agents at a price of HK$26 per share. This represents a discount of approximately 16.13% compared to the closing price of HK$31.00 per share on the Hong Kong Stock Exchange on January 14, 2026. Assuming all placement shares are fully subscribed and upon completion of the placement, the net proceeds are expected to be approximately HK$884 million. Approximately 56.54% of the net proceeds will be used to fund the company's ongoing expansion of its product portfolio through investments and potential acquisitions in the medical device industry; about 23.75% will be allocated to repay existing interest-bearing bank borrowings; and the remaining 19.71% will serve as the company's working capital and for other general corporate purposes, including employee costs and daily operational expenses.